Biosysen Limited (HKG:1355)
Hong Kong · Delayed Price · Currency is HKD 0.1530
+0.0120 (8.51%)
Jul 31, 2026, 1:28 PM HKT
Biosysen Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 51.31 | 51.31 | 40.68 | 67.66 | 63 | 70.56 |
Revenue Growth | 9.10% | 26.11% | -39.87% | 7.40% | -10.72% | 39.24% |
Gross Profit Gross Profit Growth | 14.43 | 14.43 | 20.9 | 45.35 | 36.91 | 45.5 |
Operating Income Operating Income Growth | -32.18 | -32.18 | 1.63 | -9.26 | -6.67 | 4.77 |
Net Income Net Income Growth | -43.53 | -43.53 | -21.12 | -38.18 | -7.79 | 4.98 |
Earnings Per Share EPS Growth | -0.05 | -0.05 | -0.04 | -0.09 | -0.02 | 0.01 |
EPS Growth | - | - | - | - | - | 141.34% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accommodation Accommodation Growth | 29.32 | 29.32 | 39.61 | 67.66 |
Healthcare and Beauty Healthcare and Beauty Growth | 21.99 | 21.99 | 1.08 | - |
Total Total Growth | 51.31 | 51.31 | 40.68 | 67.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2.44 | 2.44 | 13.86 | 2.21 | 6.35 | 17.05 |
Total Debt Total Debt Growth | 162.19 | 162.19 | 164.99 | 181.6 | 175.86 | 203.62 |
Net Cash (Debt) Net Cash Growth | -159.74 | -159.74 | -151.14 | -179.38 | -169.51 | -186.58 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.17 | -0.17 | -0.27 | -0.40 | -0.38 | -0.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -32.69 | -32.69 | 24.27 | 35.16 | 9.35 | 30.4 |
Capital Expenditures CapEx Growth | -16.92 | -16.92 | -0.26 | -0.65 | -2.94 | -16.34 |
Free Cash Flow Free Cash Flow Growth | -49.61 | -49.61 | 24.01 | 34.51 | 6.41 | 14.06 |
Free Cash Flow Growth | - | - | -30.42% | 438.41% | -54.41% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.13% | 28.13% | 51.38% | 67.03% | 58.58% | 64.48% |
Operating Margin | -62.72% | -62.72% | 4.01% | -13.69% | -10.58% | 6.77% |
Pretax Margin | -88.45% | -88.45% | -91.13% | -86.72% | -25.56% | -0.21% |
Profit Margin | -84.85% | -84.85% | -51.91% | -56.43% | -12.37% | 7.05% |
FCF Margin | -96.69% | -96.69% | 59.02% | 51.01% | 10.17% | 19.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 27.48 |
Forward PE | - | 22.40 | 22.40 | 22.40 | 22.40 | 22.40 |
P/FCF Ratio | - | - | 4.08 | 2.96 | 16.65 | 9.73 |
PS Ratio | 3.53 | 2.91 | 2.41 | 1.51 | 1.69 | 1.94 |